A new inhaler for delivering anti-inflammatory medication to help manage pain in COPD patients
Official title: A Novel Aerosolization and Inhalation Platform for the Pulmonary Delivery of Anti-inflammatory Agents to Distal Airways for the Enhanced Pain Management in Chronic Obstructive Pulmonary Disease (COPD)
Funded at Scientific Horizons Consulting LLC · NIH-11237357 · Data updated 2026-11-12
This study is testing a new, easy-to-use inhaler that delivers medicine directly to the deep parts of the lungs for people with COPD, aiming to help reduce inflammation and improve comfort.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scientific Horizons Consulting LLC NIH-funded |
| Lab location | 1 site (Irvine, UNITED STATES) |
| Project start | September 1, 2024 |
| Project end | August 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $55,000 |
| NIH project number | 3R43HL172316-01S1 |
| Project ID | NIH-11237357 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with chronic obstructive pulmonary disease (COPD) who experience pain associated with lung inflammation.
✕Less likely to help
Patients with COPD who do not experience significant pain or have contraindications to anti-inflammatory medications may not benefit from this research.
What this research studies
This research focuses on developing an innovative inhalation device designed to deliver anti-inflammatory agents directly to the deep lungs of patients with chronic obstructive pulmonary disease (COPD). The device features a unique atomizer that generates ultrafine aerosol particles, ensuring effective medication delivery to hard-to-reach areas of the lungs. It is user-friendly, requiring minimal effort to use, and includes a patented dose algorithm for personalized treatment. The goal is to improve pain management by addressing inflammation in the distal airways, which is often a source of discomfort for COPD patients.
Why it matters
Potential benefit: If successful, this research could significantly enhance pain management for COPD patients by providing more effective treatment options.
How similar studies have gone: Preliminary results from similar approaches have shown promise, indicating that targeted delivery of anti-inflammatory agents can improve patient outcomes.
Where this research is happening
-
Scientific Horizons Consulting LLC
Irvine, United States Active
Researchers
- Principal investigator: Gao, Xiang — Scientific Horizons Consulting LLC
- Study coordinator: Gao, Xiang
Related research
Other NIH-funded projects on the same topics.
-
New device for delivering anti-inflammatory medication to the lungs for pain relief in COPD patients
This study is testing a new inhaler that delivers anti-inflammatory medicine straight to the deep parts of the lungs for people with COPD, helping to reduce pain and improve breathing by using smart technology to track the right dose for each person.
-
Ethics-aware Multimodal AI for COPD prevention, diagnosis, and treatment
A broad AI model uses diverse health data to help predict and manage COPD in people, with an emphasis on ethics and fairness.
-
ANT2 and mitochondrial dysfunction in COPD: how energy transport affects lung repair
This project studies how a key mitochondrial transporter (ANT2) may drive aging-like cell changes and repair problems in the lungs of people with COPD.
-
Muscle weakness from high carbon dioxide in COPD
Looks at whether boosting muscle energy production helps people with COPD who retain too much carbon dioxide.
-
Video Telehealth pulmonary rehab to cut COPD readmissions
A telehealth pulmonary rehabilitation program delivered by video is being tested to help people with COPD stay out of the hospital.
-
Mobile 1/2 Video Telehealth Pulmonary Rehab to Cut COPD Readmissions
A remote pulmonary rehab program delivered via video aims to help people with COPD reduce hospital readmissions and improve daily living.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.